Voglijak GM 1mg/500mg/0.3mg Tablet SR
Marketer
Jakstar Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Voglijak GM 1mg/500mg/0.3mg Tablet SR
Diabex-Trio 1mg/500mg/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This triple-combination therapy manages type 2 diabetes in adults by regulating blood glucose. Diabex-Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan; a balanced diet, regular physical activity, and weight management (as advised by your doctor) are equally vital. Commonly reported is hypoglycemia (low blood sugar). Learn to identify its symptoms – sweating, dizziness, headache, trembling – and how to treat it. Maintain regular mealtimes and always carry a rapid-acting glucose source (e.g., sugary sweets or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Voglijak GM 1mg/500mg/0.3mg Tablet SR
No text provided to rephrase.
Uses of Voglijak GM 1mg/500mg/0.3mg Tablet SR
Managing type 2 diabetes
Major Benefits of Voglijak GM 1mg/500mg/0.3mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglijak GM 1mg/500mg/0.3mg Tablet SR whole; do not chew, crush, or divide it. Administer on an empty stomach.
Common Side effects of Voglijak GM 1mg/500mg/0.3mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglijak GM 1mg/500mg/0.3mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglijak GM 1mg/500mg/0.3mg Extended-Release tablets should be administered on an empty stomach.
How Voglijak GM 1mg/500mg/0.3mg Tablet SR works:
Each Voglijak GM SR tablet (1mg/500mg/0.3mg) contains a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Voglijak GM 1mg/500mg/0.3mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Voglijak GM 1mg/500mg/0.3mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Voglijak GM tablets (1mg/500mg/0.3mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Voglijak GM 1mg/500mg/0.3mg SR tablets in individuals with kidney impairment poses a likely risk and is best avoided. Medical advice is recommended. Furthermore, its use is contraindicated for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglijak GM 1mg/500mg/0.3mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is recommended. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its administration is contraindicated in those with severe liver disease.
What if you forget to take Voglijak GM 1mg/500mg/0.3mg Tablet SR :
Should you forget to take a Voglijak GM 1mg/500mg/0.3mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglijak GM 1mg/500mg/0.3mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently